Checkout
Cart: $0.00 - (0 items )

Everlywell raises $175 million to expand virtual care options and scale its at-home health testing

Everlywell raises 5 million to expand virtual care options and scale its at-home health testing Digital health startup Everlywell has raised a $175 million Series D funding round, following relatively fast on the heels of a $25 million Series C round it closed in February of this year. The Series D included […]

Read More

Genesis Therapeutics raises $52M A round for its AI-focused drug discovery mission

Genesis Therapeutics raises M A round for its AI-focused drug discovery mission Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. Genesis Therapeutics has a new simulation approach and cross-disciplinary team […]

Read More

Alphabet’s DeepMind achieves historic new milestone in AI-based protein structure prediction

Alphabet’s DeepMind achieves historic new milestone in AI-based protein structure prediction DeepMind, the AI technology company that’s part of Google parent Alphabet, has achieved a significant breakthrough in AI-based protein structure prediction. The company announced today that its AlphaFold system has officially solved a protein folding grand challenge that has flummoxed the […]

Read More

Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today

Moderna claims 94% efficacy for COVID-19 vaccine, will ask FDA for emergency use authorization today Drugmaker Moderna has completed its initial efficacy analysis of its COVID-19 vaccine from the drug’s Phase 3 clinical study, and determined that it was 94.1% effective in preventing people from contracting COVID-19 across 196 confirmed cases from […]

Read More

AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy

AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy AstraZeneca’s CEO told Bloomberg that the pharmaceutical company will likely conduct another global trial of the effectiveness of its COVID-19 vaccine trial, following the disclosure that the more effective dosage in the existing Phase […]

Read More

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store

Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store Oxford University’s COVID-19 vaccine, being developed in partnership with drugmaker AstraZeneca, has shown to be 70.4% effective in preliminary results from its Phase 3 clinical trial. That rate actually includes data from two different approaches to […]

Read More

Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today

Pfizer and BioNTech to submit request for emergency use approval of their COVID-19 vaccine today Two of the companies behind one of the leading COVID-19 vaccine candidates will seek approval from the U.S. Food and Drug Administration for emergency use authorization (EUA) of their preventative treatment with an application to be delivered […]

Read More

Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis

Pfizer says its COVID-19 vaccine is 95% effective in final clinical trial results analysis Drugmaker Pfizer has provided updated analysis around its COVID-19 vaccine Phase 3 clinical trial data, saying that in the final result of its analysis of the 44,000-participant trial, its COVID-19 vaccine candidate proved 95% percent effective. This is […]

Read More

Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial

Pfizer’s COVID-19 vaccine proves 90% effective in first results from Phase 3 clinical trial The COVID-19 vaccine being developed by Pfizer and its partner BioNTech has shown to be effective blocking vaccine in 90 percent of participants in its Phase 3 clinical trial, the companies announced on Monday. That’s based on data […]

Read More

Bentley is making the shift to an all-electric lineup

Bentley is making the shift to an all-electric lineup Bentley Motors, the ultra luxury automaker under VW Group, will only produce plug-in hybrid and all-electric cars starting in 2026 with an aim to drop all combustion engines in the next decade. The company said Thursday its entire lineup will be all-electric by […]

Read More

Back to top